Chinese company sues Texas power operator for blocking investment approved by CFIUS; China delays retirement age to relieve pressure on pensions; and China proposes identification and labeling requirements for AI-generated content
September 18, 2024
Legal
Beijing FTZ publishes a negative list for cross-border data transfer in the medical, retail and AI sectors. Network virtualization needs to provide data encryption protection and satisfy security requirements. Online advertisements should be identifiable as such and not mislead consumers.
September 13, 2024SPC sets forth criteria for serious money laundering cases / CLP reference:1430/24.08.19 ; promulgated: 2024-08-19 ; effective: 2024-08-20
September 13, 2024Jianwei (Jerry) Fang and Jiaying Jiang of Zhong Lun Law Firm discuss the newly released First Batch of Typical Cases for Ascertaining and Applying Foreign Law by the Supreme People's Court of China, and discover a significant shift of focus which will impact parties - and their attorneys - involved in international disputes
September 13, 2024The 2024 foreign investment negative list removes the entire manufacturing sector.
September 12, 2024China allows fully foreign-owned hospitals and foreign investment in gene technologies; China is assessing the compatibility of the international AI agreement with its own strategic plans; and China's Ministry of Finance strengthens its regulation of foreign accounting organizations, particularly for those that do not have offices in China
September 11, 2024Chinese court rules against international hotel brand for misuse of cross-border personal data; EU and China establish mechanism to address difficulties in data transfers; and High-frequency futures traders question their survival in an increasingly hostile Chinese futures market
September 05, 2024SPC sets forth criteria for serious money laundering cases and punitive damages for food safety violations. NFRA specifies the conditions for engaging in online property insurance business.
August 28, 2024U.S. lawmakers call on the government to scrutinize drugmakers' clinical trials in China; China removes restrictions for foreign investments in the manufacturing and services industries; and Cross-Boundary Wealth Connect gains 10 new additional securities firms for increased offshore investment opportunities.
August 28, 2024Export pharmaceuticals commissioned for production from a foreign pharmaceutical manufacturer may not be sold and used in the PRC
August 26, 2024
